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Abstract: Recently, seaweeds and their extracts have attracted great interest in the pharmaceutical
industry as a source of bioactive compounds. Studies have demonstrated the cytotoxic activity of
macroalgae towards different types of cancer cell models, and their consumption has been suggested
as a chemo-preventive agent against several cancers such as breast, cervix and colon cancers.
Reports relevant to the chemical properties of brown algae Padina sp. are limited and those
accompanied to a comprehensive evaluation of the biological activity on osteosarcoma (OS)
are non existent. In this report, we explored the chemical composition of French Polynesian
Padina pavonica extract (EPP) by spectrophotometric assays (total phenolic, flavonoid and tannin
content, and antioxidant activity) and by gas chromatography-mass spectrometry (GC-MS) analysis,
and provided EPP lipid and sterols profiles. Several compounds with relevant biological
activity were also identified that suggest interesting pharmacological and health-protecting effects
for EPP. Moreover, we demonstrated that EPP presents good anti-proliferative and pro-apoptotic
activities against two OS cell lines, SaOS-2 and MNNG, with different cancer-related phenotypes.
Finally, our data suggest that EPP might target different properties associated with cancer
development and aggressiveness.
Keywords: Padina pavonica; osteosarcoma; apoptosis; algae; chemo-preventive agent; phytol;
fucosterol; fatty acid
1. Introduction
Recently, seaweeds and their extracts have attracted great interest in the pharmaceutical industry
as a source of bioactive compounds [1].
A number of studies have demonstrated the cytotoxic activity of macroalgae towards different
types of cancer cell models and certain authors have suggested the consumption of algae as a
chemo-preventive agent against several cancers. In particular, brown algae have demonstrated
to be rich in unsaturated fatty acids, which block growth and systemic spread of human breast
cancer, polysaccharides and terpenoids which are considered as promising bioactive molecules
with anticancer activity [2,3]. Padina pavonica is representative of brown algae which can be found
throughout the world from warm temperate to tropical locations, including: North Carolina to Florida
in the United States, the Gulf of Mexico, throughout the Caribbean and tropical Atlantic and the
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Eastern Atlantic, Mediterranean and Adriatic Seas [4]. There are several species of algae belonging to
the genus padina. The main chemical classes of compounds found in padina species are represented by:
sterols, lipids, polysaccharides, carotenoids, polyphenols and fibers [5]. However, in addition to the
name and the geographical spread, changes can be noted also in its biochemical composition.
Although Osteosarcoma (OS) is a rare disease comprising less than 1% of cancers diagnosed in the
United States, it is the most common primary malignant bone tumor in adolescents and young adults.
OS accounts for 8.9% of cancer-related deaths and carry an overall 5-year survival rate of 60–70%
despite modern treatment protocols that combine chemotherapy and surgery [6,7]. Chemotherapy has
been established as a critical component of OS therapy, but its adverse side effects associated with the
drug resistance developed by tumors, lead to the urgent need for new and specific anticancer agents.
In this study, we aimed to demonstrate the antitumoral activity of the extract of Padina pavonica
(EPP) on human OS cells in order to provide the molecular evidences supporting the development of
EPP-based products usable as a potential chemo-preventive agent against OS.
2. Results
2.1. Chemical Composition and Antioxidant Capacity of Padina pavonica Extract
The extract of Padina pavonica (EPP) under investigation was produced by Soxhlet extraction using
acetone as solvent, starting fronds of mature from algae collected in French Polynesia in June 2014.
EPP was first chemically characterized for its total phenolic, flavonoid and tannin content through
spectrophotometric assays. The total phenolic, flavonoid and tannin contents of the seaweed were 27.0,
54.8, and 54.3 mg per g of extract, respectively, corresponding to 0.81, 1.64 and 1.63 mg per g of dry
material, respectively. The antioxidant activity was evaluated by ferric reducing antioxidant power
(FRAP) assay and resulted as 25.6 ± 0.2 µmol of Fe2+/100 mg of extract.
EPP was also examined for its lipid content by GC-MS. Hydrocarbons represented the 79.88%
of the total extract, among which 68.83% corresponded to fatty acids (FAs), 0.19% corresponded to
squalene and 10.86% to other hydrocarbon species (Table 1).
Table 1. Chemical composition (%) of EPP.
EPP (%)
Hydrocarbons
Fatty acids 68.83
Squalene 0.19
Other hydrocarbons 10.86
Total hydrocarbons 79.88
Sterols
Cholesterol 0.97
Fucosterol 7.40
Total sterols 8.37
Other compounds
α-Tocopherol 0.17
δ-Tocopherol 0.19
Phytol 5.27
Neophytadiene 5.56
2,4-di-tert-butylphenol (DTBP) 0.18
2(4H)-Benzofuranone, 5,6,7,7a-tetrahydro-4,4,7a-trimethyl-,
(R)-(Dihydroactinidiolide) 0.37
Sterols represented the 8.37% of the extract and included fucosterol and cholesterol in a percentage
of 7.40% and 0.97%, respectively (Table 1). We also calculated the ratio between fucosterol and
cholesterol (F:C) which corresponded to 7.6:1. Other noteworthy compounds identified were: α- and
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δ-tocopherol, which corresponded to 0.17 and 0.19% respectively, phytol (5.27%), neophytadiene,
a terpene compound that amounted to 5.56%, 2,4-di-tert-butylphenol (0.18%) and dihydroactinidiolide
(0.37%) (Table 1).
GC-MS analysis was also performed with a different sample preparation approach consisting in
saponification and subsequent extraction by dispersive liquid-liquid microextraction (DLLME) of EPP,
in order to analyse the most lipophilic compounds. This analysis mostly confirmed the presence of
several already identified compounds (Table 2), such as: phytol (53.85%), fucosterol (17.57%), palmitic
acid (12.00%), cholesterol (4.57%), 2,4-di-tert-butylphenol (2.99%), stearic acid (3.40%), oleic acid (0.59%),
dihydroactinidiolide (0.62%), squalene (0.19%) and δ-tocopherol (0.27%), and n-nonadecanol-1 (0.20%).
Table 2. EPP composition (%) following saponification and DLLME.
EPP (%)
Hydrocarbons
Fatty acids 17.11
Squalene 0.19
Other hydrocarbons 1.65
Total hydrocarbons 18.95
Sterols
Cholesterol 4.57
Fucosterol 17.57
Total sterols 22.14
Other compounds
δ-Tocopherol 0.27
Phytol 53.85
2,4-di-tert-butylphenol (DTBP) 2.99
6-Hydroxy-4,4,7a-trimethyl-5,6,7,7a-tetrahydrobenzofuran-2(4H)-one 0.99
2(4H)-Benzofuranone, 5,6,7,7a-tetrahydro-4,4,7a-trimethyl-,
(R)-(Dihydroactinidiolide) 0.62
n-Nonadecanol-1 0.20
EPPs FAs profile showed the presence of FAs with aliphatic chains ranging from 12 up to 22
carbon atoms (Table 3). Saturated FAs (SFAs) corresponded to 43.45% of total EPP (63.13% of total FAs).
Among these, the most abundant FA was palmitic acid with a total percentage of 34.15%, followed by
stearic (3.25%), pentadecanoic (1.95%), arachidic (0.74%), myristic (0.43%), lauric (0.47%) and behenic
(0.04%). Monounsaturated FAs (MUFAs) were 23.67% of total EPP (34.40% of total FAs). The most
abundant MUFA was palmitelaidic acid (16:1 n-7 E, 7.82%) followed by oleic acid (18:1 n-9, 7.79%)
and palmitoleic acid (16:1 n-7 Z, 6.29%). Polyunsaturated FAs (PUFAs) corresponded to 1.70% of EPP
(2.47% of total FAs). The main PUFAs found in EPP was arachidonic acid (20:4 n-6, 0.64%) followed by
linoleic (18:2 n-6, 0.53) and eicosapentanoic acid (20:5 n-3 0.24%). We also calculated the ratio between
n-6 and n-3 PUFAs which corresponded to 5.61.
Table 3. Fatty acids (%) of EPP.
Fatty Acids (FAs) EPP (%)
Saturated fatty acids (SFAs)
Lauric acid 12:0 0.47
Myristic acid 14:0 0.43
Pentadecanoic acid 15:0 1.95
Palmitic acid 16:0 34.15
Stearic acid 18:0 3.25
Arachidic acid 20:0 0.74
Behenic acid 22:0 0.04
Other SFAs 2.42
Total SFAs 43.45
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Table 3. Cont.
Fatty Acids (FAs) EPP (%)
Monounsaturated fatty acids (MUFAs)
Oleic acid (18:1 n-9) 7.79
Palmitelaidic acid (16:1 n-7 (E)) 7.82
Palmitoleic acid (16:1 n-7 (Z)) 6.29
Other MUFAs 1.76
Total MUFAs 23.67
Polyunsaturated fatty acids (PUFAs)
Linoleic acid (18:2 n-6) 0.53
Eicosapentanoic acid (20:5 n-3) 0.24
Arachidonic acid (20:4 n-6) 0.64
Other PUFAs 0.29
Total PUFAs 1.70
Total n-6 PUFAs 1.36
Total n-3 PUFAs 0.24
Ratio n-6/n-3 5.61
2.2. EPP Effects on OS Cell Viability and Proliferation
EPP inhibited SaOS-2 cell viability in a dose and time dependent trend with an IC50 after 24 h
treatment of 152.2 ± 7.7 µg/mL (Figure 1). These results were confirmed also after 48 h treatment.
On MNNG cells EPP showed a more pronounced effect on cell viability in respect of SaOS-2 cells,
with a IC50 of 87.75 ± 18.57 µg/mL after 24 h treatment and a more remarkable effect was detected
after 48 h treatment.
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Figure 1. IC50 of EPP after 24 and 48 h treatment on SaOS-2 and MNNG. IC50 was calculated using 
Graphpad. Cell viability was expressed as percentage in respect to control and EPP concentrations 
(3.1, 6.25, 12.5, 25, 50, 100 and 200 µg/mL) were reported in a logarithmic scale. 
EPP induced a decrease of proliferation in SaOS-2 and MNNG cells in a dose-dependent manner 
(Figure 2). A reduction of cells proliferation of about 51%, 70% and 82% was observed for SaOS-2 
when treated for 24 h with EPP at IC50/2, IC50 and 2*IC50 (as calculated by cell viability assay for SaOS-
2) respectively. Analogously, in MNNG cells we observed a reduction in cells count of about 30%, 
77% and 89% when treated for 24 h with EPP at IC50/2, IC50 and 2*IC50 (as calculated by cell viability 
assay for MNNG) respectively. 
Figure 1. IC50 of EPP after 24 and 48 h treatment on SaOS-2 and MNNG. IC50 was calculated using
Graphpad. Cell viability was expressed as percentage in respect to control and EPP concentrations (3.1,
6.25, 12.5, 25, 50, 100 and 200 µg/mL) were reported in a logarithmic scale.
EPP induced a decrease of proliferation in Sa S-2 and M NG cells in a dose-dependent manner
(Figure 2). A reduction of cells proliferation of about 51%, 70% and 82% was observed for Sa - when
treated for 24 h with EPP at IC50/2, IC50 and 2*IC50 (as calculated ll viability assay for aOS-2)
respectively. Analogously, in MNNG cells we observed a reduction in cells count of about 30%, 77%
and 89% when treated for 24 h with EPP at IC50/2, IC50 and 2*IC50 (as calculated by cell viability assay
for MNNG) respectively.
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Figure 2. SaOS-2 and MNNG cell proliferation after 24 h treatment with EPP at IC50/2, IC50 and 2*IC50
in starved conditions determined by the Scepter 2.0 cell counter. Data are expressed as percentage in
respect to control and presented as mean ± SD, **** p < 0.0001.
2.3. EPP Effects on OS Cell and Nuclear Morphology
Bright-field images showed noticeable morphological changes in both OS cell lines, moving from
control to the highest concentration of EPP (Figure 3A). After 24 h treatment with EPP at IC50 and
2*IC50, cells lost their original elongated shape and become roundi l bbing. A reductio in cell
number a d dime sion, as well as cytoplasm conde sation wer also bserve th SaOS-2 and
MNNG cells, representing a clear sign of the activity of the treatment.
To evaluate whether EPP exhibited cytotoxicity through apoptosis in both OS cell lines, a DAPI
staining analysis was performed to observe nuclear morphological changes (Figure 3B). Such analysis
demonstrated that the exposure of OS cells to EPP induced apoptosis in a dose dependent manner; indeed,
both SaOS-2 and MNNG cells showed loss of regular shape and well-defined boundaries. Moreover, at the
highest concentration tested (2*IC50), EPP exhibited a more remarkable ap ptotic effect agai st MNNG
than SaOS-2 with greater nuclear fragmentation, chromatin condensation and nuclear blebbing.
These evidences were confirmed by the igh percentage of late apoptotic cells rather than
SaOS-2 cells (par. 2.4).
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2.4. EPP Induces Apoptosis in OS Cells
The exposure of SaOS-2 and MNNG cells to EPP resulted in dose-dependent increase of the
percentage of small diameter cells (6–9 µm), compared to control (Figure 4). The gradual increase in
the percentage of cells in the small particle fraction after treatment with different concentrations of
EPP can be regarded as an index of late cell apoptosis.
To confirm the pro-apoptotic effect of EPP, we performed the Annexin V-FITC/propidium iodide
(PI) assay on SaOS-2 and MNNG cells treated with EPP (at their relative IC50/2, IC50 and 2*IC50) for
6 h (Figure 5A,B and Table 4). SaOS-2 apoptotic cells were, roughly, completely absent in the untreated
culture, as expected for cancer cells: 88.04± 3.33% of non-apoptotic (AnV−/PI−), 11.17± 2.94 of early
apoptotic (AnV+/PI−) and 0.79 ± 0.47% of late apoptotic (AnV+/PI+). When cells were treated with
progressively higher concentrations of EPP, the number of early apoptotic and late apoptotic cells increased
in a dose-dependent manner (IC50/2: 21.80 ± 8.31% of AnV+/PI− and 31.83 ± 8.20% of AnV+/PI+;
IC50: 10.46 ± 1.07% of AnV+/PI and 83.43 ± 2.76% AnV+/PI+; 2*IC50: 9.60 ± 3.53% of AnV+/PI and
90.40 ± 3.53% of AnV+/PI+). MNNG cells (Figure 5A,B) had a quite similar trend, finding a very low
percentage of apoptotic cells (6.08 ± 2.84%) in the untreated culture and an increasing percentage of
early and late apoptotic cells with progressively higher concentrations of EPP (IC50/2: 2.05 ± 1.26% of
AnV+/PI− and 72.46± 9.12% of AnV+/PI+; IC50: 2.99± 2.12% of AnV+/PI and 90.34± 4.27 AnV+/PI+;
2*IC50: 5.63± 5.63 of AnV+/PI and 93.67± 5.32% of AnV+/PI+). On MNNG cells, EPP demonstrated a
greater pro-apoptotic effect. In fact, in MNNG cells treated with IC50/2, we detected a greater percentage
of late apoptotic cells in respect of SaOS-2 challenged with the same EPP concentration (AnV+/PI+:
72.46± 9.12% and 31.83± 8.20%, respectively).
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Figure 5. (A) Apoptosis assessment using Annexin V-FITC/PI staining and fluorescent microscopy of
SaOS-2 and MNNG OS cells line treated with EPP/Acetone (IC50/2, IC50, 2*IC50) for 6 h. Viable cells
did not show any kind of coloration (Anv−/PI−). Cells stained in green (AnV+/PI−) were considered
as early apoptotic cells, while cells stained both in green and red (Anv+/PI−) were considered as late
apoptotic cells. Cells are shown at ×40 magnification. Arrows indicate co-localization. (B) Histograms
show the percentage of non-apoptotic(AnV−/PI−), early apoptotic (AnV+/PI−) and late apoptotic
(AnV+/PI+) cells in respect to control. The quantitative assessment of apoptosis was obtained observing
merged images. Results were obtained from three different experiments in triplicate, **** p < 0.0001.
Table 4. Apoptosis in SaOS-2 and MNNG OS cells treated with EPP at IC50/2, IC50 and 2*IC50
after 6 h treatment. Percentage (±SD) of non-apoptotic (AnV−/PI−), early apoptotic (AnV+/PI−)
and late apoptotic (AnV+/PI+) cells are reported. Results were obtained from three different
experiments in triplicate. Results were obtained from three different experiments in triplicate. p-values
were calculated, by one-way ANOVA with post hoc Dunnett test, comparing the percentages of
non-apoptotic cells (AnV−/PI−) in control and treated conditions, **** p < 0.0001.
SaOS-2 OS Cells Non-ApoptoticAnV−/PI− (%) ± SD
Early Apoptotis
AnV+/PI− (%) ± SD
Late Apoptotis
AnV+/PI+ (%) ± SD p-Value
CTR 88.04 ± 3.33 11.17 ± 2.94 0.79 ± 0.47
IC50/2 46.36 ± 16.31 21.80 ± 8.31 31.83 ± 8.20 ****
IC50 6.11 ± 1.72 10.46 ± 1.07 83.43 ± 2.76 ****
2*IC50 0.00 9.60 ± 3.53 90.40 ± 3.53 ****
MMNG OS Cells Non-apoptoticAnV−/PI− (%) ± SD
Early Apoptotis
AnV+/PI− (%) ± SD
Late Apoptotis
AnV+/PI+ (%) ± SD p-Value
CTR 93.90 ± 1.54 4.30 ± 1.06 1.78 ± 1.78
IC50/2 25.48 ± 8.11 2.05 ± 1.26 72.46 ± 9.12 ****
IC50 6.67 ± 2.89 2.99 ± 2.12 90.34 ± 4.27 ****
2*IC50 0.69 ± 0.69 5.63 ± 5.63 93.67 ± 5.32 ****
To study if caspases activation was involved in EPP-induced apoptosis, we finally evaluated
the activation of caspase-3 by western blot analysis. The immunoreactive band of cleaved caspase-3
increased in a dose-dependent manner after 6 h treatment with EPP (Figure 6). In SaOS-2 cell lines
we detected a 2.6 and 7.1-fold increase in the activation of caspase-3 when treated with EPP at IC50
and 2*IC50 respectively. On the contrary in MNNG cells, we observed a dose-dependent increase in
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the activation of caspase-3. The immunoreactive band was significantly higher than SaOS-2 already
after treatment with the lowest concentration of EPP (2.4-fold at IC50/2) and increased over the other
two concentrations (3.2-fold at IC50 and 3.7-fold at 2*IC50).
Lower panel: Graph reports the decrease of procaspase-3 and the increase of cleaved caspase-3 in
a dose dependent manner after 6 h of treatment with IC50/2, IC50 and 2*IC50 EPP. Values are calculated
as a ratio of band volume of procaspase-3 or caspase-3 over band volume of GAPDH.Mar. Drugs 2018, 16, x FOR PEER REVIEW  9 of 19 
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Figure 6. EPP treated SaOS-2 and MNNG OS cells line western blotting images of procaspase-3,
cleaved caspase-3 and GAPDH. Data are expresse as fold-change in respect t control and presented
as mean ± SD. Results wer obtained fro i ferent experiments in triplicate, **** p < 0 0001.
3. Discussion
Recently, natural bioact ve comp unds derived from marine organisms, especially those obtained
from se w eds, have r ceived great r attention. Their hig lev l of bio i sity makes them a
considerable reservoir for active compounds as they are able to produce a great variety of secondary
metabolites characterized by a wide range of biological activities. Many previous studies demonstrated
the remarkable benefits of seaweeds on human health and protection against chronic disease [8] due to
their content in proteins, lipids and fatty acids, polysaccharides and antioxidant compounds. It has
been demonstrated that fatty acids extracted from marine algae block growth and spread of human
breast cancer [9]. In addition, polysaccharides and terpenoids from brown algae have demonstrated to
be promising bioactive mol cules with anticancer activity [3].
In this work, for the first time the acetonic extract of Padi a pavonica (EPP), a brown seaweed
collected fr m French Polynesia, was chemically characterized and demonstrated to have a strong
pro-apoptotic effect on human OS cells.
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Reports relevant to the chemical properties of brown algae Padina sp. are limited and those
providing a detailed description of the chemical profile accompanied to a comprehensive evaluation of
the biological activity for Padina pavonica from French Polynesia are nonexistent.
We first characterized EPP for its total phenolic, flavonoid and tannin content, providing the first
chemical report on French Polynesian Padina pavonica.
In our extract, total phenolic compounds amounted to 27 mg per g of extracts (0.81 mg per g
of dry material). Considering the acetone as the solvent used for the extraction, our is a remarkable
quantity if compared to total phenolic compounds found by Khaled et al. in Lebanese Padina pavonica
(10.76 mg per g of the methanolic extract) [10] and by CAF et al. in Turkish Mediterranean
Padina pavonica (0.96 mg per g of the aqueous extract and 1.76 mg per g of the methanolic extract) [11].
Pinteus et al. in Padina pavonica from Portugal, found values of 44.61 and 10.48 mg per g of extract when
using methanol and dichloromethane respectively as extraction solvents [12]. In their work Hlila et al.
determined the total phenolic content of aqueous and acetonic extract of Tunisian Padina pavonica,
with values corresponding to 57.34 and 90.61 mg per g of extract, respectively [13].
Phenolic compounds, one of the most important class of natural compounds, are commonly
found in brown algae where they exert a protective effect toward adverse environmental conditions.
They have been reported to possess several biological activities including anti-oxidant, anti-bacterial
and anti-allergic and anti-diabetes, and to be involved in the protection against several human diseases
such as cancer, coronary heart disease, inflammatory and neurodegenerative diseases and aging [14,15].
With regard to flavonoid content, Padina pavonica from French Polynesia appeared to be rich
in flavonoids, showing a value of 54.8 mg per g of extract. This is a relevant data if compared to
previous report for Australian Padina sp., which reported a total flavonoid content of 20.74 mg per g of
ethanol extract [16]. Flavonoids are an important class of phenolic compounds, that contribute to the
antioxidant activity of algae extracts.
About tannin content, their concentrations vary greatly among different species of brown
seaweeds, as well as among different geographical areas [12]. The tannin content of our extract
(54.3 mg per g) appeared similar to that showed by Dang et al., who founded a tannin content of
56.17 ± 0.22 mg per g of the Australian Padina sp. extract [16].
Previous studies reported the antioxidant activity of some brown algae measured with the
FRAP method. Agregán et al. measured the in vitro antioxidant activity of aqueous extracts of
three brown seaweed from the Atlantic Ocean, in the area of Camariñas, Spain. They found FRAP
values of 7.52, 51.66 and 26.93 µmol/g of extract for Ascophyllum nodosum, Fucus vesiculosus and
Bifurcaria bifurcata, respectively [14]. Kelman et al. quantified the antioxidant activity of methanol
extracts from 37 samples of algae, comprising 30 species of Hawaiian algae from 27 different genera.
They showed that the brown algae as a group had the highest mean antioxidant activity among
Hawaiian algae with a mean FRAP value of 3.55 ± 3.16 µM/µg extract [15]. The antioxidant activity of
our extract from French Polynesia Padina pavonica appeared in line with the previous works on brown
algae, given that acetone is not the chosen solvent for the extraction of antioxidant compounds.
Different Padina species possess different sterol compositions. In French Polynesian Padina pavonica
we tested, fucosterol appeared to be exceptionally high (7.40% of EPP) in respect of cholesterol
(0.97% of EPP), leading to a ratio between fucosterol and cholesterol (F:C) of 7.6:1. Comparing our
sterols pattern with literature data, we can see that F:C for Padina pavonica from French Polynesia
is higher than what previously found in the Aegean Sea Padina pavonica, 0.7:1 [17], Adriatic Sea
Padina pavonica, 0.3:1 [2] and in Turkish Mediterranean Sea Padina pavonica [11]. The differences
found in the sterol composition could be attributed to differences in the ecological conditions, life
cycle of the algae and seasonal variations. [2,18,19]. Fucosterol is the main phytosterol in brown
algae [20]. Many studies have described the biological and pharmacological effects of fucosterol
including antidiabetic, antioxidant, anti-inflammatory, ability to reduce blood cholesterol levels in in
hyper- and normocholesterolemic subjects. Fucosterol has been demonstrated to possess pro-apoptotic
activity toward several cancer cell lines (colon carcinoma [21], breast carcinoma [22], promyelocytic
Mar. Drugs 2018, 16, 504 10 of 19
leukemia [21]) by promoting activation of caspase-3 [20]. These data strongly suggest the potential
anti-cancer activity of EPP, analogously with what reported for Turbinaria ornata sterols [21] or fucosterol
from Turbinaria conoides [23]. Furthermore, fucosterol has bone regenerative effects as demonstrated
by in vivo and vitro studies [24]. In an estrogen-deficient ovariectomized (OVX) animal model, oral
administration of fucosterol ameliorated several bone-quality parameters (bone mineral density, bone
microarchitecture and BV/TV ratio, osteocalcin and CTx serum biomarkers [24]. At cell level, fucosterol
increased MG63 osteblast-like cells proliferation, alkaline phosphatase activity and mineralization
capacity, while preventing osteoclasts differentiation and RANK expression [24–26].
Several terpenes and terpenoid compounds were identified in P. pavonica. Terpenoids are
considered as promising bioactive molecules in the search for anticancer drugs, due to their effect
in inhibiting mitotic cell division [27]. Various diterpenes have been identified in several species
of the genus Cystoseira with antitumoral and antioxidant activities [9]. Among these, squalene
appears to influence several biochemical and physiological activities which are interesting for the
treatment of cancer [28], it can suppress the growth of tumor cells, partially prevent the development of
chemically-induced cancer and cause regression of some already existing tumors [29]. A rich squalene
diet enhances chemoterapeutic activity by increasing immune system efficiency and by lowering
blood cholesterol content [28,29]. Squalene supplementation stimulates the reticuloendothelial system,
resulting in a marked increase in cellular and non-specific immune function [28]. Evidence suggests that
squalene might assist in maintaining white cell counts during radiation treatment [28], and, in animal
models, supplementation is associated with prolonged survival time subsequent to exposure to lethal
doses of radiation [28]. Squalene’s ability to inhibit ornithine decarboxylase (ODC) is also of significant
interest in cancer prevention and treatment [29]. Cancer cells are known to utilize polyamines as growth
substrates, and since ODC is a rate-limiting enzyme in the generation of many of the polyamines,
ongoing cancer research has been, and is currently, investigating agents with the ability to interfere
with this enzyme’s activity [28].
In EPP, phytol—an acyclic monounsaturated diterpene alcohol and constituent of
chlorophyll—was found in a remarkable amount. The anticancer activity of phytol against several
tumor cell lines in vitro has been assessed [30–32], as well as its capacity to induce the apoptosis in
hepatocellular carcinoma cells [33] and in human gastric adenocarcinoma AGS [34].
Other identified compounds with relevant biological activity are: neophytadiene,
dihydroactinidiolide, 2,4-di-tert-butylphenol (DTBP) and n-Nonadecanol-1. Neophytadiene, is a
terpene compound that possess a strong bactericidal, antifungal, antipyretic, analgesic, antioxidant
and anti-inflammatory properties [35]; dihydroactinidiolide has cytotoxic effects against five human
carcinoma cell lines and one melanoma cell line [36,37]; DTBP was found to possess potent antioxidant
effect [38,39] in addition to fungicidal and cytotoxic activity against HeLa cancer cell line [40].
Finally, n-Nonadecanol-1, one of the major detected component in Ceratonia siliqua pods essential oil,
demonstrated a strong cytotoxic effect against two cancer human cell lines, HeLa and MCF-7 [41].
As far as the FAs composition, palmitic acid appears to be the predominant FA in our extract,
as in Dictyotales order brown algae [2,11,17,42,43]. Palmitic acid has been reported to have to have
antioxidant, hypocholesterolmic nematicide, pesticide, antiandrogenic flavor, hemolytic and 5-alpha
reductase inhibitor activity. In French Polynesian Padina pavonica, a significant percentage of oleic
and palmitoleic acid was also detected. Oleic acid attracted attention as the Mediterranean diet,
characterized by high olive oil (rich in oleic acid) consumption, has been linked to a protective effect
against cancer [44]. A wide range of studies have been conducted on breast cancer, where a potential
protective effect of oleic acid has been described [45,46]. In addition, epidemiological studies suggest
that olive oil may have a protective effect on colorectal cancer development [47]. In this regard, animal
studies have also shown that dietary olive oil prevented the development of colon carcinomas in rats,
confirming that olive oil may have chemopreventive properties against colon carcinogenesis [48,49].
Oleic acid has been reported to act synergistically with cytotoxic drugs, enhancing their antitumor
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effect [50,51]. Eventually, palmitoleic has been demonstrated to possess antitumor effect on Ehrlich
ascites tumor [52].
Although C18 and C20 PUFAs are reported to be characteristic of brown algae [2,53],
the concentrations of PUFAs in our Padina pavonica appeared unusually low compared to PUFAs
composition of Turkish Mediterranean Sea Padina pavonica [11], Padina boryana from the Saudi
Arabian coast [2], or Padina pavonica from Jordan [53] and other characterized brown algae from
the Bohai Sea [54]. By contrast, in our material, SFAs represented the prevalent percentage of total FAs
(63.85% of total FAs and 41. 03% of total EPP).
The differences in EPP chemical profiles observed between present and literature data can be
explained on the basis of environmental and experimental conditions. Several parameters are known
to influence the composition of phenolic compounds or FAs produced by the same species of algae:
stage of algal growth, harvest season, geographic location, genetic diversity etc. [11,13]. As an example,
higher amount of high-quality phenolic compounds is generated during the hot climate and during
the early stage of the growth in order to prevent the photooxidative damage and sea grazers [13].
In addition, also the extraction methodology (techniques, solvent, temperature, raw material) notably
affect the yield of extracted compounds from a quantitative and a qualitative point of view [55].
As far as it regards the anti-OS activity of EPP, anti-OS effects of Padina pavonica from French
Polynesia has not been clearly studied yet. Therefore, this is the first work that tests and demonstrates
the anti-OS properties of Padina pavonica from French Polynesia.
According to our results, EPP presents good anti-proliferative and pro-apoptotic activities against
two osteosarcoma cell lines, namely MNNG and SaOS-2. These two cell lines were chosen based on
their intrinsic properties, as they have opposite cancer-related phenotypes. According to Lauvrak [56],
MNNG cells have been defined as very aggressive in terms of tumorigenicity, colony forming ability,
migration/invasion and proliferation capacity; on the contrary, SaOS-2 cells have been classified as
poorly aggressive. Moreover, these two cell lines possess a different p53 mutation status, being MNNG
p53 mutant and SaOS-2 p53-null [57]. This approach let us speculate on a possible mechanism of action
of EPP. In the present study EPP was found to be much more active against MNNG that SaOS-2 cells
suggesting that EPP may upregulate p53 expression [58] and thus induce p53-dependent apoptosis in
human OS cells by the activation of extrinsic pathways. Finally, we evaluated EPP toxicity in human
primary osteoblasts and found that these cells were significantly less affected by the antiproliferative
and pro-apoptotic activities of EPP (data not shown)
In literature there are several works that confirm the antitumoral activities for Padina pavonica.
The dichloromethane extract of Padina pavonica was found to be cytotoxic towards the KB tumor
cell line. An oxysterol, (hydroperoxy-24 vinyl-24 cholesterol), was identified as being responsible for
this activity [59]. Likewise, the cytotoxic and apoptotic effects of Padina pavonica methanol extract
against human cervix (HeLa) and breast cancer (MDA-MB-453) cell lines have been reported [60].
The observed anticancer activity could be connected to the rich content of phenolics, in particular the
antiproliferative effects of polyphenols were reported to be due to the regulation of apoptosis, decreased
Bcl-2 levels and increased Bax, Caspase-8 and Caspase-10 levels, and Fas death receptor signalling [61].
Moreover, glycosides, sulfated polysaccharides and carotenoids of the brown seaweed were found to
act as potential chemoterapeutic or chemopreventive agents through the induction of caspases or cell
cycle arrest [60,62–65]. In agreement with the works above mentioned and considering the present
characterization of EPP (Tables 1–3), we might assume that the main constituents responsible for the
antitumoral effect—that we observed in our work—may be identified in fucosterol, in two terpenoid
compounds, such as dihydroactinidiolide and phytol, of which EPP was found to be rich, and in
oleic acid. Notwithstanding, it should be also considered that macroalgae extracts are complex matrices
and that biological activities of such extracts might not be closely related to a specific compound but
rather to the mixture of components that can act synergistically. Therefore, any biological activity can
be hardly explained with the analysis of a specific algae component.
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4. Materials and Methods
4.1. Collection of Padina pavonica and Preparation of the Algae Extract (EPP)
The algae (Padina pavonica (Linnaeus) Thivy) were collected from the coastal area of Moorea,
French Polynesia, in June 2014. Fronds of mature plants (20 mm) were harvested and then rinsed with
water to remove salt and the associated debris. The cleaned material was air-dried and stored in a
dehumidified chamber to remove the residual moisture. Once completely dried, the algae material was
ground into a fine powder and extracted with acetone in a Soxhlet extractor. After that, the mixture was
filtered through filter paper and the filtrate was collected. The solution was dried by rotary evaporator
and the resulting material was kept in the refrigerator until the analyses.
4.2. Total Phenolic Content
The quantitative assay of the total phenolic compounds was determined by the Folin-Ciocalteu
method [66]. A stock standard solution of 0.5 mg/mL gallic acid was prepared in 95% methanol,
and then working standard solutions were prepared in the range 0.05–0.45 mg/mL. 100 µL of
standard/sample (5 mg/mL in DMSO) were mixed to 200 µL of 10% Folin-Ciocalteu reagent in
DI water and 700 µL of 0.7 M Na2CO3. Each solution was prepared in triplicate. The samples and the
standards were incubated for 30 min in the dark. The absorbance was red at 765 nm using a Tecan
Spark 20M multimode microplate reader. The total phenolic content was expressed as mg gallic acid
per gram of extract.
4.3. Total Flavonoid Content
The determination of the content of flavonoid compounds was carried out according to the
aluminum chloride colorimetric method [67]. A stock standard solution of 1 mg/mL of quercetin
was prepared in methanol, and then working standard solutions were prepared in the range of
0.05–0.30 mg/mL. 500 µL of standard/sample (1 mg/mL in DMSO) were mixed to 100 µL of 10% AlCl3
in 1 M potassium acetate and 3.3 mL of methanol. Each solution was prepared in triplicate. After 30 min
of incubation, the absorbance was measured at 430 nm using a Tecan Spark 20M multimode microplate
reader. The results were expressed as mg of quercetin per gram of extract.
4.4. Total Condensed Tannins Content
The determination of the content of condensed tannins was performed according to the Broadhurst
vanillin-HCl method [68]. A stock standard solution of 1 mg/mL of catechin was prepared in methanol,
and then working standard solutions were prepared in the range of 0.05–0.30 mg/mL. 500 µL of
standard/sample (2 mg/mL in DMSO) were mixed to 3 mL of 4% vanillin solution in methanol and
1.5 mL of concentrated HCl. Each solution was prepared in triplicate. The samples and the standard
were incubated for 15 min in the dark. The absorbance was red at 765 nm using a Tecan Spark 20M
multimode microplate reader. The results were expressed as mg of catechin per gram of extract.
4.5. FRAP Scavenging Ability for the Antioxidant Activity
The determination of the antioxidant activity of the extract was performed on the method
of FRAP assay [69], based on the redox reaction of the reduced oxidant Fe(III) complexed by
TPTZ (2,4,6-Tris(2-pyridyl)-s-triazine). The FRAP reagent for the calibration curve was prepared
mixing 0.3 M acetate buffer (pH 3.6), 0.01 M TPTZ and DI water in proportion 10:1:1, respectively.
A 0.001 M FeSO4·7H2O solution in DI water was used as standard for the calibration levels. The sample
was analyzed mixing 100 µL of the extract solution at 5 mg/mL in DMSO with 900 µL of DI water and
2 mL of FRAP reagent, obtained mixing 0.3 M acetate buffer, 0.01 M TPTZ and a 0.02 M FeCl3·6H2O
solution in proportion 10:1:1, respectively. All the reagents were prepared fresh. Each solution was
prepared in triplicate. All the solutions were incubated for 30 min in the dark. Then the absorbance
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was measured at 593 nm using a Tecan Spark 20M multimode microplate reader. The scavenging
ability was expressed as µmol of Fe2+ per 100 mg of extract.
4.6. GC-MS Analysis
5 mg of EPP were dissolved in 50 µL of pyridine and 75 µL of
bis(trimethylsilyl)trifluoroacetamide (BSTFA). The mixture was heated at 80 ◦C for 30 min and
analysed by GC/MS and finally 3 µL were injected manually in the GC-MS.
For the analysis of the most lipophilic compounds, EPP was submitted to saponification and
dispersive liquid-liquid microextraction (DLLME) [70] before the derivatization step. Briefly, 30 mg of
EPP were dispersed in 2 mL of methanol; 1 mL of 2 M methanolic KOH was added and the mixture
was heated in a water bath for 1 h at 80 ◦C shaking vigorously every 15 min. Then 1.2 mL of 1 M
HCl was added and the mixture was vortex-mixed. An aliquot of 400 µL was transferred to a glass
centrifuge tube and 1.6 mL of DI water was added. The DLLME was performed injecting rapidly 1 mL
of a mixture of acetone (900 µL) and chloroform (100 µL) into the glass tube. The tube was closed and
gently shaken by hand for 1 min. After that the tube was centrifuged at 3000 rpm for 5 min and the
lower phase was collected with a microsyringe. An aliquot of 50 µL of the collected phase was mixed
with 30 µL of pyridine and 30 µL of BSTFA and heated in a water bath for 30 min at 80 ◦C. An aliquot
of 3 µL was injected manually in the GC-MS.
Analysis was performed with an Agilent 6890 Series gas chromatograph (Santa Clara, CA, USA)
coupled with an Agilent 5973 quadrupole mass analyser (Santa Clara, CA, USA) equipped
with the MSD ChemStation software (software version D.03.00). A Phenomenex ZB-5MS plus
(30 m × 0.25 mm × 0.25 µm) column (Torrance, CA, USA) was used. The oven temperature was
programmed as follow: the initial column temperature of 90 ◦C (1 min) was increased to 110 ◦C at a
rate of 5 ◦C/min; then it was increased to 233 ◦C at a rate of 10 ◦C/min and held for 5 min; then it was
increased to 300 ◦C at a rate of 20 ◦C/min and held for 5 min and then it was increased to 325 ◦C at a
rate of 10 ◦C/min and held for 10 min. The total run time was 40.65 min. Helium was used as a carrier
gas at a flow rate of 1.4 mL/min. The split ratio was 50:1 and the injector temperature was 285 ◦C.
For electron ionization (EI) we used the ionization voltage 70 eV. The temperatures used were 150 ◦C
for the MS Quad and 230◦C for the MS Source. Full scan mass spectra were acquired at the mass range
of 35–550 Da.
The identification of the compounds in the GC-MS chromatograms was based on a comparison of
the electron ionization (EI) spectra with the NIST MS library database and, in addition, the study of the
mass spectrum of each peak was carried out to further elucidate the identification of the compounds
with a higher probability. Standards of fucosterol and cholesterol were also analysed to obtain the exact
retention time for the identification. Considering the instrumental technique used, the discrimination
between isomers was not possible in certain cases.
4.7. Cell Cultures
Human OS SaOS-2 (ATCC-HTB-85) and MNNG (ATCC-CRL-1547) cells were obtained from
American Type Culture Collection (ATCC, Manassas, VA, USA) and cultured as described [71–73] in
DMEM containing 10% v/v FBS, 100 mg/mL penicillin and 100 mg/mL streptomycin. Cultures were
mainteined at 37 ◦C in a humidified atmosphere of 5% CO2. Comparative analysis was performed
with cell populations at the same generation.
4.8. Cell Viability and Proliferation
SaOS-2 and MNNG cells were seeded in a 96-well plate at a density of 8 × 103 or 3 × 103
cells/well, respectively, and cultured until sub-confluence (70–75% confluence). Cells were serum
starved (FBS 0.1%) for 24 h and then treated with different concentrations of EPP (3.1, 6.25; 12.5, 25,
50 100 and 200 µg/mL) in starvation medium. Controls were performed treating cells with DMSO
0.2% v/v, corresponding to the higher concentration of the compound. After 24 h of treatment, cells
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were washed with sterile PBS and MTT was added to a final concentration of 1 mg/mL. After a
3.5 h incubation, cells were lysed with 100 µL DMSO. The absorbance was measured at 550 nm
and percentage of cell viability was calculated relative to control and EPP half-maximal inhibitory
concentration (IC50) was calculated by GraphPad Prism software. The experiment was repeated
three times.
Cell proliferation was evaluated by cell counting with Scepter™ 2.0 Cell Counter (Merck Millipore,
Burlington, MA, USA). SaOS-2 and MNNG cells were seeded in 24-well plate at a density of 4 × 104
and 3× 104 cells/well, respectively, and cultured until sub-confluence (70–75% confluence). Cells were
serum starved (FCS 0.1%) for 24 h and then treated with different concentrations of EPP corresponding
to IC50/2, IC50 and 2*IC50 in starvation medium. After 24 h of treatment, cells were washed with
sterile PBS and detached by trypsin. Cells were collected in clean tubes and counted, percentage of cell
proliferation was calculated relative to control.
4.9. Cell Morphology
Cell morphology of SaOS-2 and MNNG cells was recorded with bright field microscopy
(Zeiss AxioLabA1, Oberkochen, Germany). Cell morphology images were collected after 24 h treatment
with EPPat different concentrations (IC50/2, IC50 and 2*IC50) in starved conditions (FCS 0.1%).
4.10. Nuclear Staining with 4′, 6-Diamidine Phenylindole (DAPI)
SaOS-2 and MNNG cells were seeded in 8-well chambered slide at a density of 8 × 103 and 6 × 103
cells/well respectively. After treatment with EPP for 24 h, the slides were washed with PBS and fixed
in 70% ethanol for 30 min. Finally, the slides were washed twice with PBS and mounted with
fluoroshield mounting medium containing DAPI. Images were captured by fluorescence microscopy
(Zeiss AxioLabA1, Oberkochen, Germany).
4.11. Cell Diameter Analysis
As proved by Tahara et al. [74] the Scepter 2.0 cell counter could be used to evaluate apoptosis in
an accurate and reproducible way by measuring cell diameter. Cell size distributions were shown as
histograms on the monitor of the Scepter™ 2.0 Cell Counter, and these data were analyzed with the
Scepter™ 2.0 Software Pro computer software. Before the cell diameter were analyzed, the upper and
lower gates of the counter were adjusted manually to eliminate small particles. Data regarding cell
diameter are presented as the mean ± standard deviation (SD) values of triplicated experiments.
4.12. Annexin V/Propidium Iodide Assay
Apoptosis was detected in SaOS-2 and MNNG cells treated with EPP for 6 h, by FITC Annexin
V/Dead Cell Apoptosis Kit (Molecular Probes; Invitrogen Corp., Eugene, OR, USA) following
manufactures protocol. A total of 300 cells from each sample were scored by using a fluorescence
microscope (Zeiss AXIO LAB AI, Oberkochen, Germany) and were assessed as viable cells (AnV−/PI−),
early apoptotic cells (AnV+/PI−), late apoptosis (AnV+/PI+) and necrotic cells (AnV−/PI+).
4.13. Western Blot Analysis
After treatment with EPP, cells were washed with sterile PBS, lysed with RIPA buffer, added
with phosphate and protease inhibitors, and then disrupted by sonication for 5 min in an ice bath.
Protein concentration was assessed by BCA protein assay. 20 µg of protein were resolved by
12% SDS–PAGE and transferred onto nitrocellulose membrane. The membrane was blocked in
TBS, 0.1% Tween 20, 5% w/v nonfat dry milk at 4 ◦C with gentle shaking, ON. The membrane
was incubated with anti-caspase 3 (rabbit polyclonal IgG, 1:1000 Cell Signaling) and anti-GAPDH
HRP-conjugated (1:50,000) primary antibodies, in the same buffer, ON at 4 ◦C. The blot was
washed three times with PBS and incubated with anti-rabbit HRP-conjugated secondary antibody
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(Sigma-Aldrich, Saint Louis, MO, USA) 1:80,000 for 1 h at room temperature. The membrane was
washed three times with PBS and immunoreactive bands were detected using ECL (Luminata
Crescendo, Merck Millipore, Burlington, MA, USA) and images acquired by LAS4000 (GE Healthcare,
Chicago, IL, USA). The optical densities of immunoreactive bands were analysed by ImageQuant
TL software (GE Healthcare, Chicago, IL, USA, V 7.0) using GAPDH as a loading normalizing factor.
The experiment was performed in triplicate.
4.14. Statistical Analysis
Experiments were performed in triplicate. Data were expressed as mean± SD. Differences between
the values were tested for statistical analysis of variance (ANOVA) using two-tailed Student’s t-test.
The values of p < 0.05 were considered to be statistically different to control.
5. Conclusions
The extract of brown algae Padina pavonica under investigation exhibited an interesting
pharmacological potential with relevant health-protecting effects. Our findings confirmed this
macroalgae as a promising and unlimited source of new functional food ingredients and
bioactive compounds. Moreover, this study provides convincing and integrated evidences that EPP
possesses anti-cancer properties towards osteosarcoma cell lines and can be used as a nutraceutical
tool to prevent bone-related diseases or to support the current treatment protocols for osteosarcoma.
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